Monday, June 8 is the Deadline for Next Round of HHS-requested Data to Inform Remdesivir Distribution

The Department of Health and Human Services yesterday announced that the next deadline for submitting data to inform the agency’s distribution of its supply of remdesivir is Monday, June 8 at 8 p.m. ET. HHS is requesting the same data as last month’s remdesivir request – that is, the number of currently hospitalized COVID-19 patients, and of those hospitalized, the number requiring placement in intensive care units (ICUs).

 

Hospitals should again submit the data using the HHS TeleTracking web portal. See the AHA’s May 11 Special Bulletin for additional details on what specific data to submit and how to enter it into TeleTracking. Registered users of TeleTracking received an email yesterday announcing this next round of data collection.

 

Last month, HHS requested initial data to inform its distribution of remdesivir. While the agency had planned to request the data weekly, it later canceled the weekly reporting and indicated it would ask for an additional round of data collection when needed.

 

Note that the TeleTracking portal is one of the options HHS has made available for its request for daily reporting of certain bed capacity and utilization data. Hospitals that already use TeleTracking for their daily reporting do not need to do anything differently for this remdesivir data collection, other than ensure their data are in by the deadline. Those hospitals that use another reporting mechanism for daily reporting (e.g., National Healthcare Safety Network, or state reporting) should still report the six admissions and ICU data fields into TeleTracking for this remdesivir-related request.

 

For issues with accessing the TeleTracking portal or questions about the data, contact TeleTracking Technical Support at 1-877-570-6903.

Related Resources

Action Alert
Member
As Congress considers additional COVID-19 relief actions, we need to make sure hospital and health systems' priorities are at the top of its list. Additional…
Special Bulletin
Public
The Department of Health and Human Services (HHS) yesterday announced it struck a deal with Gilead to secure 500,000 additional treatment courses of remdesivir…
Letter/Comment
Public
  Dear Secretary Azar and Administrator Verma: On behalf of America’s hospitals and health systems, we urge you to delay the effective date of the…
Other Resources
COVID-19 has hit first and the hardest in big cities. But rural areas across the U.S. are starting to see more cases. Health care teams at…
Other Resources
In response to the COVID-19 pandemic, communities served by Hackensack Meridian Health in New Jersey did not hesitate to provide support, donating food…
Letter/Comment
Public
AHA today urged the Centers for Medicare & Medicaid Services to temporarily extend certain waivers and make others permanent beyond the COVID-19 public…